Cargando…
How to improve adherence of guidelines for localized testicular cancer surveillance: A Delphi consensus study
Stage-I testicular germ-cell tumor (TGCT) has excellent cure rates. Surveillance is fully included in patient’s management, particularly during the first years of follow-up. Surveillance guidelines differ between the academic societies, mainly concerning imaging frequency and long-term follow-up. We...
Autores principales: | Da Silva, Angélique, Fléchon, Aude, Coquan, Elodie, Planchamp, François, Culine, Stéphane, Murez, Thibaut, Méjean, Arnaud, Pasquier, David, Chevreau, Christine, Fizazi, Karim, Thiery-Vuilemin, Antoine, Joly, Florence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619048/ https://www.ncbi.nlm.nih.gov/pubmed/36324582 http://dx.doi.org/10.3389/fonc.2022.1036190 |
Ejemplares similares
-
Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial
por: Culine, Stéphane, et al.
Publicado: (2023) -
Early objective response may not be a prognostic factor of survival for patients with metastatic urothelial carcinoma: from a retrospective analysis of a cohort of 113 patients
por: Roubaud, Guilhem, et al.
Publicado: (2015) -
Multicentric phase II trial of TI‐CE high‐dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors
por: Chevreau, Christine, et al.
Publicado: (2021) -
PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?
por: Giraudet, Anne-Laure, et al.
Publicado: (2021) -
REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study
por: Vauchier, Charles, et al.
Publicado: (2022)